APO RESEARCH · REPORT
Biopharmaceutical Logistic
Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.
Product & engineering
Understand the product.
Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.
Selected research
Industry Research
Biopharmaceutical Logistic Industry Research Report 2026
Market perspective
Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.
Market competition is intense. Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken) and DB Schenker, etc. are the leaders of the industry, and they hold key technologies, with high-end customers; have been formed in the monopoly position in the industry. The top six players got about 20% market shares. North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Report Scope
Read the full market overview
This report quantifies the global Biopharmaceutical Logistic market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biopharmaceutical Logistic.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biopharmaceutical Logistic Market by Company
Deutsche Post DHL
Kuehne + Nagel
FedEx
AmerisourceBergen
UPS (Marken)
DB Schenker
XPO Logistics
Panalpina
Nippon Express
GEODIS
VersaCold
Agility
DSV
Sinotrans
Kerry Logistics
SF Express
CEVA
CH Robinson
Air Canada Cargo
Biopharmaceutical Logistic Segment by Type
Cold Chain Logistics
Non-cold Chain Logistics
Biopharmaceutical Logistic Segment by Application
Ground Shipping
Sea Shipping
Air Shipping
Biopharmaceutical Logistic Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Logistic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Logistic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Logistic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biopharmaceutical Logistic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cold Chain Logistics
- Non-cold Chain Logistics
Applications
- Ground Shipping
- Sea Shipping
- Air Shipping
Companies covered
- Deutsche Post DHL
- Kuehne + Nagel
- FedEx
- AmerisourceBergen
- UPS (Marken)
- DB Schenker
- XPO Logistics
- Panalpina
- Nippon Express
- GEODIS
- VersaCold
- Agility
- DSV
- Sinotrans
- Kerry Logistics
- SF Express
- CEVA
- CH Robinson
- Air Canada Cargo
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biopharmaceutical Logistic by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cold Chain Logistics
- 2.2.3 Non-cold Chain Logistics
- 2.3 Biopharmaceutical Logistic by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Ground Shipping
- 2.3.3 Sea Shipping
- 2.3.4 Air Shipping
- 2.4 Assumptions and Limitations
3 Biopharmaceutical Logistic Breakdown Data by Type
- 3.1 Global Biopharmaceutical Logistic Historic Market Size by Type (2021-2026)
- 3.2 Global Biopharmaceutical Logistic Forecasted Market Size by Type (2027-2032)
4 Biopharmaceutical Logistic Breakdown Data by Application
- 4.1 Global Biopharmaceutical Logistic Historic Market Size by Application (2021-2026)
- 4.2 Global Biopharmaceutical Logistic Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biopharmaceutical Logistic Market Perspective (2021-2032)
- 5.2 Global Biopharmaceutical Logistic Growth Trends by Region
- 5.2.1 Global Biopharmaceutical Logistic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biopharmaceutical Logistic Historic Market Size by Region (2021-2026)
- 5.2.3 Biopharmaceutical Logistic Forecasted Market Size by Region (2027-2032)
- 5.3 Biopharmaceutical Logistic Market Dynamics
- 5.3.1 Biopharmaceutical Logistic Industry Trends
- 5.3.2 Biopharmaceutical Logistic Market Drivers
- 5.3.3 Biopharmaceutical Logistic Market Challenges
- 5.3.4 Biopharmaceutical Logistic Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biopharmaceutical Logistic Players by Revenue
- 6.1.1 Global Top Biopharmaceutical Logistic Players by Revenue (2021-2026)
- 6.1.2 Global Biopharmaceutical Logistic Revenue Market Share by Players (2021-2026)
- 6.2 Global Biopharmaceutical Logistic Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biopharmaceutical Logistic Head Office and Area Served
- 6.4 Global Biopharmaceutical Logistic Players, Product Type & Application
- 6.5 Global Biopharmaceutical Logistic Manufacturers Established Date
- 6.6 Global Biopharmaceutical Logistic Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biopharmaceutical Logistic Market Size (2021-2032)
- 7.2 North America Biopharmaceutical Logistic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biopharmaceutical Logistic Market Size by Country (2021-2026)
- 7.4 North America Biopharmaceutical Logistic Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biopharmaceutical Logistic Market Size (2021-2032)
- 8.2 Europe Biopharmaceutical Logistic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biopharmaceutical Logistic Market Size by Country (2021-2026)
- 8.4 Europe Biopharmaceutical Logistic Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biopharmaceutical Logistic Market Size (2021-2032)
- 9.2 Asia-Pacific Biopharmaceutical Logistic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biopharmaceutical Logistic Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biopharmaceutical Logistic Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biopharmaceutical Logistic Market Size (2021-2032)
- 10.2 South America Biopharmaceutical Logistic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biopharmaceutical Logistic Market Size by Country (2021-2026)
- 10.4 South America Biopharmaceutical Logistic Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biopharmaceutical Logistic Market Size (2021-2032)
- 11.2 Middle East & Africa Biopharmaceutical Logistic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biopharmaceutical Logistic Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biopharmaceutical Logistic Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Deutsche Post DHL
- 12.1.1 Deutsche Post DHL Company Information
- 12.1.2 Deutsche Post DHL Business Overview
- 12.1.3 Deutsche Post DHL Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.1.4 Deutsche Post DHL Biopharmaceutical Logistic Product Portfolio
- 12.1.5 Deutsche Post DHL Recent Developments
- 12.2 Kuehne + Nagel
- 12.2.1 Kuehne + Nagel Company Information
- 12.2.2 Kuehne + Nagel Business Overview
- 12.2.3 Kuehne + Nagel Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.2.4 Kuehne + Nagel Biopharmaceutical Logistic Product Portfolio
- 12.2.5 Kuehne + Nagel Recent Developments
- 12.3 FedEx
- 12.3.1 FedEx Company Information
- 12.3.2 FedEx Business Overview
- 12.3.3 FedEx Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.3.4 FedEx Biopharmaceutical Logistic Product Portfolio
- 12.3.5 FedEx Recent Developments
- 12.4 AmerisourceBergen
- 12.4.1 AmerisourceBergen Company Information
- 12.4.2 AmerisourceBergen Business Overview
- 12.4.3 AmerisourceBergen Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.4.4 AmerisourceBergen Biopharmaceutical Logistic Product Portfolio
- 12.4.5 AmerisourceBergen Recent Developments
- 12.5 UPS (Marken)
- 12.5.1 UPS (Marken) Company Information
- 12.5.2 UPS (Marken) Business Overview
- 12.5.3 UPS (Marken) Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.5.4 UPS (Marken) Biopharmaceutical Logistic Product Portfolio
- 12.5.5 UPS (Marken) Recent Developments
- 12.6 DB Schenker
- 12.6.1 DB Schenker Company Information
- 12.6.2 DB Schenker Business Overview
- 12.6.3 DB Schenker Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.6.4 DB Schenker Biopharmaceutical Logistic Product Portfolio
- 12.6.5 DB Schenker Recent Developments
- 12.7 XPO Logistics
- 12.7.1 XPO Logistics Company Information
- 12.7.2 XPO Logistics Business Overview
- 12.7.3 XPO Logistics Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.7.4 XPO Logistics Biopharmaceutical Logistic Product Portfolio
- 12.7.5 XPO Logistics Recent Developments
- 12.8 Panalpina
- 12.8.1 Panalpina Company Information
- 12.8.2 Panalpina Business Overview
- 12.8.3 Panalpina Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.8.4 Panalpina Biopharmaceutical Logistic Product Portfolio
- 12.8.5 Panalpina Recent Developments
- 12.9 Nippon Express
- 12.9.1 Nippon Express Company Information
- 12.9.2 Nippon Express Business Overview
- 12.9.3 Nippon Express Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.9.4 Nippon Express Biopharmaceutical Logistic Product Portfolio
- 12.9.5 Nippon Express Recent Developments
- 12.10 GEODIS
- 12.10.1 GEODIS Company Information
- 12.10.2 GEODIS Business Overview
- 12.10.3 GEODIS Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.10.4 GEODIS Biopharmaceutical Logistic Product Portfolio
- 12.10.5 GEODIS Recent Developments
- 12.11 VersaCold
- 12.11.1 VersaCold Company Information
- 12.11.2 VersaCold Business Overview
- 12.11.3 VersaCold Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.11.4 VersaCold Biopharmaceutical Logistic Product Portfolio
- 12.11.5 VersaCold Recent Developments
- 12.12 Agility
- 12.12.1 Agility Company Information
- 12.12.2 Agility Business Overview
- 12.12.3 Agility Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.12.4 Agility Biopharmaceutical Logistic Product Portfolio
- 12.12.5 Agility Recent Developments
- 12.13 DSV
- 12.13.1 DSV Company Information
- 12.13.2 DSV Business Overview
- 12.13.3 DSV Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.13.4 DSV Biopharmaceutical Logistic Product Portfolio
- 12.13.5 DSV Recent Developments
- 12.14 Sinotrans
- 12.14.1 Sinotrans Company Information
- 12.14.2 Sinotrans Business Overview
- 12.14.3 Sinotrans Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.14.4 Sinotrans Biopharmaceutical Logistic Product Portfolio
- 12.14.5 Sinotrans Recent Developments
- 12.15 Kerry Logistics
- 12.15.1 Kerry Logistics Company Information
- 12.15.2 Kerry Logistics Business Overview
- 12.15.3 Kerry Logistics Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.15.4 Kerry Logistics Biopharmaceutical Logistic Product Portfolio
- 12.15.5 Kerry Logistics Recent Developments
- 12.16 SF Express
- 12.16.1 SF Express Company Information
- 12.16.2 SF Express Business Overview
- 12.16.3 SF Express Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.16.4 SF Express Biopharmaceutical Logistic Product Portfolio
- 12.16.5 SF Express Recent Developments
- 12.17 CEVA
- 12.17.1 CEVA Company Information
- 12.17.2 CEVA Business Overview
- 12.17.3 CEVA Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.17.4 CEVA Biopharmaceutical Logistic Product Portfolio
- 12.17.5 CEVA Recent Developments
- 12.18 CH Robinson
- 12.18.1 CH Robinson Company Information
- 12.18.2 CH Robinson Business Overview
- 12.18.3 CH Robinson Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.18.4 CH Robinson Biopharmaceutical Logistic Product Portfolio
- 12.18.5 CH Robinson Recent Developments
- 12.19 Air Canada Cargo
- 12.19.1 Air Canada Cargo Company Information
- 12.19.2 Air Canada Cargo Business Overview
- 12.19.3 Air Canada Cargo Revenue in Biopharmaceutical Logistic Business (2021-2026)
- 12.19.4 Air Canada Cargo Biopharmaceutical Logistic Product Portfolio
- 12.19.5 Air Canada Cargo Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst